Sotera Health (NASDAQ:SHC) Shares Sold by Xponance Inc.

Xponance Inc. cut its position in shares of Sotera Health (NASDAQ:SHC) by 41.5% during the 2nd quarter, according to the company in its most recent filing with the SEC. The firm owned 13,415 shares of the company’s stock after selling 9,510 shares during the quarter. Xponance Inc.’s holdings in Sotera Health were worth $159,000 as of its most recent filing with the SEC.

Several other hedge funds also recently modified their holdings of the company. CWM LLC increased its holdings in shares of Sotera Health by 86.1% in the second quarter. CWM LLC now owns 2,146 shares of the company’s stock valued at $25,000 after buying an additional 993 shares in the last quarter. Acadian Asset Management LLC raised its position in shares of Sotera Health by 728.0% during the second quarter. Acadian Asset Management LLC now owns 9,381 shares of the company’s stock worth $111,000 after purchasing an additional 8,248 shares during the period. Sandia Investment Management LP purchased a new stake in shares of Sotera Health during the first quarter valued at $120,000. Securian Asset Management Inc. boosted its position in shares of Sotera Health by 23.0% in the 1st quarter. Securian Asset Management Inc. now owns 10,178 shares of the company’s stock valued at $122,000 after purchasing an additional 1,900 shares during the period. Finally, Wedmont Private Capital acquired a new position in shares of Sotera Health in the 2nd quarter valued at $127,000. 91.03% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Several brokerages have commented on SHC. Royal Bank of Canada reiterated an “outperform” rating and issued a $17.00 target price on shares of Sotera Health in a report on Tuesday, August 6th. Barclays raised their price objective on shares of Sotera Health from $14.00 to $17.00 and gave the stock an “overweight” rating in a research note on Tuesday, August 6th. Two analysts have rated the stock with a hold rating and four have given a buy rating to the stock. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average target price of $15.70.

Sotera Health Stock Down 1.1 %

SHC stock opened at $16.09 on Thursday. Sotera Health has a 12-month low of $10.71 and a 12-month high of $17.44. The company has a quick ratio of 2.59, a current ratio of 2.93 and a debt-to-equity ratio of 5.46. The company has a market cap of $4.56 billion, a price-to-earnings ratio of 84.69 and a beta of 2.07. The company has a 50 day moving average of $15.43 and a two-hundred day moving average of $12.99.

Sotera Health (NASDAQ:SHC) last released its earnings results on Monday, August 5th. The company reported $0.19 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.15 by $0.04. Sotera Health had a net margin of 3.65% and a return on equity of 47.26%. The company had revenue of $277.00 million during the quarter, compared to the consensus estimate of $266.45 million. During the same quarter in the prior year, the firm earned $0.19 EPS. The company’s revenue was up 8.6% compared to the same quarter last year. On average, equities analysts anticipate that Sotera Health will post 0.64 earnings per share for the current fiscal year.

Insiders Place Their Bets

In other news, Director Gtcr Investment Xi Llc sold 10,000,000 shares of the firm’s stock in a transaction on Friday, September 6th. The shares were sold at an average price of $15.03, for a total transaction of $150,300,000.00. Following the transaction, the director now owns 49,215,301 shares in the company, valued at approximately $739,705,974.03. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Insiders own 55.12% of the company’s stock.

Sotera Health Profile

Sotera Health Company engages in the provision of sterilization, lab testing, and advisory services in the United States and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. It provides mission-critical end-to-end sterilization services, including gamma and electron beam irradiation, and ethylene oxide processing, as well as designs, installs, and maintains gamma irradiation systems.